I will be posting a number of studies soon on H2 antagonists, especially famotidine. It looks like they are extremely versatile drugs with benefits in conditions like Parkinson, autism, heart failure, cancer, etc. The reason I am posting about famotidine is that it is the safest of the H2 antagonists, has no known drug interactions, and has studies supporting its use in the conditions above. Oh, and it synergizes very well with cyproheptadine.
Here is a study showing that a normal daily dose of 20mg famotidine lowered PTH from 311 to 168 in just 4 weeks. Granted, the study was in people with secondary hyperparathyroidism due to kidney issues, but I think that underscores its effectiveness even more.
http://www.karger.com/Article/PDF/186580
Here is a study showing that a normal daily dose of 20mg famotidine lowered PTH from 311 to 168 in just 4 weeks. Granted, the study was in people with secondary hyperparathyroidism due to kidney issues, but I think that underscores its effectiveness even more.
http://www.karger.com/Article/PDF/186580